Literature DB >> 6015903

Dietary treatment in tyrosinemia (tyrosinosis). With a note on the possible recognition of the carrier state.

J Gentz, B Lindblad, S Lindstedt, L Levy, W Shasteen, R Zetterstrom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6015903     DOI： 10.1001/archpedi.1967.02090160081006

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN： 0002-922X


× No keyword cloud information.
  11 in total

1.  Liver transplantation in a 23-year-old tyrosinaemia patient: effects on the renal tubular dysfunction.

Authors:  E A Kvittingen; E Jellum; O Stokke; A Flatmark; A Bergan; G Sødal; S Halvorsen; E Schrumpf; E Gjone
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

2.  Homotransplantation of the liver in a patient with hepatoma and hereditary tyrosinemia.

Authors:  R O Fisch; E R McCabe; D Doeden; L J Koep; J G Kohlhoff; A Silverman; T E Starzl
Journal:  J Pediatr       Date:  1978-10       Impact factor: 4.406

3.  Evidence for the possible formation of a toxic tyrosine metabolite by the liver microsomal drug metabolizing system.

Authors:  J C David
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

4.  Diagnosis and treatment of tyrosinosis.

Authors:  A Fairney; D Francis; R S Ersser; J W Seakins; D Cottom
Journal:  Arch Dis Child       Date:  1968-10       Impact factor: 3.791

5.  Recovery after dietary treatment of an infant with features of tyrosinosis.

Authors:  J T Harries; J W Seakins; R S Ersser; J K Lloyd
Journal:  Arch Dis Child       Date:  1969-04       Impact factor: 3.791

6.  A syndrome of hereditary tyrosinemia in mink (Mustela vison Schreb.).

Authors:  K Christensen; P Fischer; K E Knudsen; S Larsen; H Sørensen; O Venge
Journal:  Can J Comp Med       Date:  1979-07

7.  Therapeutic trials in the murine model of hereditary tyrosinaemia type I: a progress report.

Authors:  M Grompe; K Overturf; M al-Dhalimy; M Finegold
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

8.  Hereditary tyrosinemia and the heme biosynthetic pathway. Profound inhibition of delta-aminolevulinic acid dehydratase activity by succinylacetone.

Authors:  S Sassa; A Kappas
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

9.  Hereditary tyrosinemia. Formation of succinylacetone-amino acid adducts.

Authors:  S Manabe; S Sassa; A Kappas
Journal:  J Exp Med       Date:  1985-09-01       Impact factor: 14.307

10.  On the enzymic defects in hereditary tyrosinemia.

Authors:  B Lindblad; S Lindstedt; G Steen
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.